Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 186,986 | 424,426 | 80,951 | 357,399 | 734,577 |
| Cost of Goods | 98,929 | 55,777 | 34,086 | 181,765 | 434,593 |
| Gross Profit | 88,057 | 368,649 | 46,865 | 175,634 | 299,984 |
| Operating Expenses | 214,618 | 313,969 | 359,719 | 420,278 | 427,766 |
| Operating Income | -125,632 | 55,457 | -312,768 | -243,879 | -127,189 |
| Interest Expense | 2,859 | 3,124 | 4,316 | 4,601 | 4,169 |
| Other Income | -2,982 | 5,532 | 24,362 | 63,971 | -34,783 |
| Pre-tax Income | -131,473 | 57,865 | -292,722 | -184,509 | -166,141 |
| Income Tax | -697 | -143 | 1,183 | -2,260 | 2,472 |
| Net Income Continuous | -130,776 | 58,008 | -293,905 | -182,249 | -168,613 |
| Net Income | $-130,776 | $58,008 | $-293,905 | $-182,249 | $-168,613 |
| EPS Basic Total Ops | -1.26 | 0.65 | -3.41 | -2.40 | -2.15 |
| EPS Basic Continuous Ops | -1.26 | 0.65 | -3.41 | -2.39 | -2.15 |
| EPS Diluted Total Ops | -1.26 | 0.58 | -3.41 | -2.30 | -2.15 |
| EPS Diluted Continuous Ops | -1.26 | 0.56 | -3.41 | -2.25 | -2.15 |
| EBITDA(a) | $-114,311 | $65,524 | $-303,725 | $-236,657 | $-118,842 |